Israel’s Medivie Therapeutics  Signs Off On Big Euro Deal – Issues Warning To Govt

Ganjapreneur have reported, “Israeli medical cannabis company Medivie Therapeutics and its subsidiary High Pharma has announced a $110 million deal to cultivate and manufacture medical cannabis products for a European client in what the company calls the largest deal of its kind in Israel to date”


Go to Source

Powered by WPeMatico